Enveric Biosciences Inc (ENVB) concluded trading on Thursday at a closing price of $0.35, with 7.39 million shares of worth about $2.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.02% during that period and on January 16, 2025 the price saw a loss of about -1.93%. Currently the company’s common shares owned by public are about 10.39M shares, out of which, 9.50M shares are available for trading.
Stock saw a price change of -15.82% in past 5 days and over the past one month there was a price change of -3.69%. Year-to-date (YTD), ENVB shares are showing a performance of -2.32% which decreased to -71.54% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.30 but also hit the highest price of $2.92 during that period. The average intraday trading volume for Enveric Biosciences Inc shares is 389.89K. The stock is currently trading -4.02% below its 20-day simple moving average (SMA20), while that difference is down -5.70% for SMA50 and it goes to -38.77% lower than SMA200.
Enveric Biosciences Inc (NASDAQ: ENVB) currently have 10.39M outstanding shares and institutions hold larger chunk of about 9.09% of that.
The stock has a current market capitalization of $3.64M and its 3Y-monthly beta is at 0.58. It has posted earnings per share of -$2.56 in the same period. It has Quick Ratio of 4.56 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENVB, volatility over the week remained 7.62% while standing at 12.12% over the month.
Analysts are in expectations that Enveric Biosciences Inc (ENVB) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -1.6 in the same quarter a year ago.
